GLP-1 agonists might protect the heart indirectly through their effects on weight, blood sugar, blood pressure, and inflammation
Drucker DJ (2016) The Cardiovascular Biology of Glucagon-like Peptide-1
Whether it is drug cost, conditions that require the payer to approve them, the patients health insurance plan, or the unaffordability of a plan that would cover weight loss, there are real-world barriers in our health care system, Shah said
This differs from the common mild gastrointestinal side effects of GLP-1 agonists and requires immediate medical assessment
GIPR fx/fx mice were as described in ref
For instance, Anthem uses a three-tier system and designates brand-name Mounjaro and Wegovy as tier 2 drugs